KyleColvettMD

Radiation Oncology • Johnson City, TN

Medical Director

Join to view full profile

Dr. Colvett is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Colvett's full profile

Already have an account?

Office
400 N State Of Franklin Rd
Cancer Treatment Center
Johnson City, TN 37604
Phone+1 423-431-6000

Fax+1 423-431-6060
Is this information wrong?

Summary

Busy private practice radiation oncologist with teaching appointments and clinical trial emphasis.

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1993 - 1996
East Tennessee State University/Quillen College of MedicineInternship, Surgery, 1992 - 1993
East Tennessee State University James H. Quillen College of MedicineClass of 1992

Certifications & Licensure

TN State Medical License 1996 - 2026
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Service Award American Board of Radiology, 2022
Reader’s Choice Awards—Favorite Cancer Doctor Johnson City Press, 2016-2017, 2019-2021
Highest Patient Satisfaction Score in Region Press Ganey, 2014-2015, 2017
America’s Top Docs Castle Connolly, 2008-2009, 2011, 2017
Healthcare Heroes TriCities Health, 2005, 2009
Servant’s Heart Milligan University, 2006
James Gibson Award Medical Staff Leadership Johnson City Medical Center— Ballad Health, 2005
Forty Under Forty The Business Journal, 2002
Join now to see all

Clinical Trials

Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers Start of enrollment: 2018 Jul 12
Completed
Phase 2
ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients Start of enrollment: 2018 Oct 03
Completed
Phase 3
Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. Start of enrollment: 2021 Feb 11
Terminated
Phase 2, Phase 3
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867) Start of enrollment: 2019 Jun 25
Active, not recruiting
Phase 3
Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases Start of enrollment: 2002 Mar 01
Completed
Phase 3
A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942) Start of enrollment: 1996 Mar 01
Completed
Phase 2
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
Completed
Not Applicable
MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ Start of enrollment: 2003 Aug 01
Completed
Phase 2
Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma Start of enrollment: 2013 Jul 01
Active, not recruiting
Early Phase 1
Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall Start of enrollment: 2004 Jun 17
Terminated
Phase 2
Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node Start of enrollment: 2013 Jan 01
Withdrawn
Phase 3
Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node Start of enrollment: 2012 Jul 19
Active, not recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Biophysical studies with spatially correlated ions. 2. Multiple scattering, experimental facility, and dosimetry.
Colvett RD, Rohrig N> ;Radiation research.
Letter: Beta emission from encapsulated sources of californium-252.
Dicello JF, Colvett RD, Gross W, Kraljevic U> ;Radiation research.
RBE and OER determinations for radium and californium 252.
Hall EJ, Roizin-Towle LA, Colvett RD> ;Radiology.
The biophysical properties of 3.9-GeV nitrogen ions. I. Dosimetry.
Gross W, Colvett RD> ;Radiation research.
6 citations
PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiother...
Marcelo Bonomi, Dukagjin M Blakaj, Rafi Kabarriti, Kyle Colvett, Vinita Takiar, Matthew Biagioli, Voichita Bar-Ad, Sharad Goyal, Brian Muzyka, Kenneth Niermann, Nacer ...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Jul 1
Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurre...
Anderson CM, Lee CM, Saunders D, Curtis AE, Dunlap NE, Nangia C, Lee AS, Kovoor P, Bar-Ad V, Pedadda AV, Holmlund J, Downs M, Sonis ST> ;International journal of radiation oncology, biology, physics. 2022-06-17
Superoxide Dismutase as an Intervention for Radiation Therapy-Associated Toxicities: Review and Profile of Avasopasem Manganese as a Treatment Option for Radiation-Ind...
Sonis ST> ;Drug design, development and therapy. 2021-03-05
1 citations
Scalping injuries: report of a historical case.
Lewis Jv, Colvett Kt> ;Journal of the Tennessee Medical Association. 1993 Apr 1
52 citations
Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
Carryn M. Anderson, Christopher M. Lee, Deborah P. Saunders, Amarinthia Curtis, Neal Dunlap, Chaitali Singh Nangia, Arielle S. Lee, Sharon M. Gordon, Philip Kovoor, Ro...> ;Journal of Clinical Oncology. 2019 Oct 16
2 citations
The history of radiation oncology.
Kyle T. Colvett> ;Southern Medical Journal. 2006 Oct 1
Nonsurgical treatment of laryngeal cancer.
Kyle T Colvett> ;The New England Journal of Medicine. 2004 Mar 4
11 citations
Atypical presentation of metastatic basal cell carcinoma.
Kyle T. Colvett, Floranne C. Wilson, Ryan A. Stanton> ;Southern Medical Journal. 2004 Mar 1
20 citations
Radiation-related arterial disease
Tony Katras, Ulises Baltazar, Kyle T. Colvett, Daniel S. Rush, Julie Dunn, Stanton Pe> ;The American Surgeon. 1999 Dec 1
6 citations
High PCNA index in meningiomas resistant to radiation therapy.
Kyle T. Colvett, D. W. Hsu, Mei Su, Rita M. Lingood, Francisco S. Pardo> ;International Journal of Radiation Oncology, Biology, Physics. 1997 Jun 1
5 citations
Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
Kyle T. Colvett, Alex F. Althausen, Barbara Bassil, Niall M. Heney, Francis V. McGovern, Hugh H. Young, Donald S. Kaufman, Anthony L. Zietman, William U. Shipley> ;Journal of Surgical Oncology. 1996 Nov 1
12 citations
Bilateral breast carcinoma after radiation therapy for Hodgkin's disease.
Kyle T. Colvett> ;Southern Medical Journal. 1995 Feb 1
9 citations
MULTIPLE BEAU'S LINES IN A PATIENT WITH FEVER OF UNKNOWN ORIGIN
K L Colvett, D Patel, J K Smith> ;Southern Medical Journal. 1993 Dec 1
Join now to see all

Journal Articles

Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer
Kyle T. Colvett MD, Alex F. Althausen MD, Barbara Bassil MD, Niall M. Heney MD, Francis V. McGovern MD, Hugh H. Young II MD, Donald S. Kaufman MD, Journal of Surgical Oncology, 11/1996

Committees

Chief of Staff, Executive Committee 1999 - 2001

Professional Memberships

Alpha Omega Alpha Honor Medical Society - AOA
Member
American College of Radiology - ACR
Member
American Roentgen Ray Society - ARRS
Member
American Society for Radiation Oncology - ASTRO
Member
American College of Physician Executives - ACPE
Member
Royal Society of Medicine
Member
Association of Military Surgeons of the United States
Member
American Association for Cancer Research - AACR
Member
American Brachytherapy Society
Member
American College of Radiation Oncology
Member
American Society of Clinical Oncology - ASCO
Member

KyleColvettMD

Dr. Colvett is on Doximity

Summary

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Committees

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.